Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Pamela S Herrera"'
Autor:
Thu T. Duong, Vidyullatha Vasireddy, Pavitra Ramachandran, Pamela S. Herrera, Lanfranco Leo, Carrie Merkel, Jean Bennett, Jason A. Mills
Publikováno v:
Stem Cell Research, Vol 27, Iss , Pp 140-150 (2018)
Choroideremia (CHM) is a rare monogenic, X-linked recessive inherited retinal degeneration resulting from mutations in the Rab Escort Protein-1 (REP1) encoding CHM gene. The primary retinal cell type leading to CHM is unknown. In this study, we explo
Externí odkaz:
https://doaj.org/article/cf3438c1f6194219b24035c1fd245aa0
Autor:
Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V. Amelsberg, Sean M. Devlin, Raymone Pajarillo, John B. Slingerland, Silvia Beghi, Pamela S. Herrera, Paul Giardina, Annelie Clurman, Emmanuel Dwomoh, Gabriel Armijo, Antonio L. C. Gomes, Eric R. Littmann, Jonas Schluter, Emily Fontana, Ying Taur, Jae H. Park, Maria Lia Palomba, Elizabeth Halton, Josel Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel-Angel Perales, Craig W. Freyer, Alfred Garfall, Shannon Gier, Sunita Nasta, Daniel Landsburg, James Gerson, Jakub Svoboda, Justin Cross, Elise A. Chong, Sergio Giralt, Saar I. Gill, Isabelle Riviere, David L. Porter, Stephen J. Schuster, Michel Sadelain, Noelle Frey, Renier J. Brentjens, Carl H. June, Eric G. Pamer, Jonathan U. Peled, Andrea Facciabene, Marcel R. M. van den Brink, Marco Ruella
Publikováno v:
Nature Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84c76e49b962bb0b05f019f3b4b8a6af
https://doi.org/10.1038/s41591-022-02069-7
https://doi.org/10.1038/s41591-022-02069-7
Autor:
Daniel K. Wells, Howard Y. Chang, Santosha Vardhana, Mirela Berisa, Pamela S. Herrera, Ansuman T. Satpathy, Craig B. Thompson, Marcel R.M. van den Brink, Madeline A. Hwee, Bryan King, Melody Smith, Kathryn E. Yost, Justin R. Cross
Publikováno v:
Nature immunology
The majority of tumor-infiltrating T cells exhibit a terminally exhausted phenotype, marked by a loss of self-renewal capacity. How repetitive antigenic stimulation impairs T cell self-renewal remains poorly defined. Here, we show that persistent ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e7fbdd53dbcf8c45e02164860000a07
https://doi.org/10.1038/s41590-020-0725-2
https://doi.org/10.1038/s41590-020-0725-2
Autor:
Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V. Amelsberg, Sean M. Devlin, Raymone Pajarillo, John B. Slingerland, Silvia Beghi, Pamela S. Herrera, Paul Giardina, Annelie Clurman, Emmanuel Dwomoh, Gabriel Armijo, Antonio L. C. Gomes, Eric R. Littmann, Jonas Schluter, Emily Fontana, Ying Taur, Jae H. Park, Maria Lia Palomba, Elizabeth Halton, Josel Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel-Angel Perales, Craig W. Freyer, Alfred Garfall, Shannon Gier, Sunita Nasta, Daniel Landsburg, James Gerson, Jakub Svoboda, Justin Cross, Elise A. Chong, Sergio Giralt, Saar I. Gill, Isabelle Riviere, David L. Porter, Stephen J. Schuster, Michel Sadelain, Noelle Frey, Renier J. Brentjens, Carl H. June, Eric G. Pamer, Jonathan U. Peled, Andrea Facciabene, Marcel R. M. van den Brink, Marco Ruella
Publikováno v:
Nat Med
Anti-CD19 chimeric antigen receptor (CAR) T cell therapy has led to unprecedented responses in patients with high-risk hematologic malignancies. However, up to 60% of patients still experience disease relapse and up to 80% of patients experience CAR-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::652f668ef24deebfa0ecdc51fc4070ee
https://pubmed.ncbi.nlm.nih.gov/36253610
https://pubmed.ncbi.nlm.nih.gov/36253610
Autor:
Patsy M. Nishina, Jeannette L. Bennicelli, Jieyan Pan, Ji Yun Song, Frans P.M. Cremers, Tomas S. Aleman, Ilan McNamara, Shangzhen Zhou, Gui-Shuang Ying, Junwei Sun, Lanfranco Leo, Puya Aravand, Pamela S. Herrera, Arkady Lyubarsky, Ivan Shpylchak, Zhangyong Wei, Albert M. Maguire, Sergei Nikonov, Jennifer Pham, Robert K. Koenekoop, Wei Pan, Daniel J Bennett, Ronald Roepman, Jimmy de Melo, Jason A. Mills, Nicoletta Commins, Anneke I. den Hollander, Jean Bennett
Publikováno v:
Molecular Therapy, 26, 1581-1593
Molecular Therapy, 26, 6, pp. 1581-1593
Molecular Therapy, 26, 6, pp. 1581-1593
Item does not contain fulltext Most genetically distinct inherited retinal degenerations are primary photoreceptor degenerations. We selected a severe early onset form of Leber congenital amaurosis (LCA), caused by mutations in the gene LCA5, in orde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b80acd76e10a6b2b81dbe0a0d9eb96
https://doi.org/10.1016/j.ymthe.2018.03.015
https://doi.org/10.1016/j.ymthe.2018.03.015
Autor:
Pamela S. Herrera, Vidyullatha Vasireddy, Pavitra S. Ramachandran, Jason A. Mills, Carrie E. Merkel, Lanfranco Leo, Thu T. Duong, Jean Bennett
Publikováno v:
Stem Cell Research, Vol 27, Iss, Pp 140-150 (2018)
Choroideremia (CHM) is a rare monogenic, X-linked recessive inherited retinal degeneration resulting from mutations in the Rab Escort Protein-1 (REP1) encoding CHM gene. The primary retinal cell type leading to CHM is unknown. In this study, we explo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3cabea795aaa7a8d24c039daa4e54c2
http://www.sciencedirect.com/science/article/pii/S1873506118300151
http://www.sciencedirect.com/science/article/pii/S1873506118300151
Autor:
Miguel-Angel Perales, Melody Smith, Gabriel K Armijo, James W. Janc, Marcel R.M. van den Brink, Nicole Lee, Joseph J. Buggy, Pamela S Herrera, Kate A. Markey, Emmanuel A Dwomoh, Marina Burgos da Silva, Chi L. Nguyen, Sarah Lindner, Romina Ghale
Publikováno v:
Blood. 138:3814-3814
Background Acute graft-versus-host disease (aGVHD) remains a major limitation of allogeneic hematopoietic cell transplantation (allo-HCT) despite prophylactic immunosuppression. Not all patients who develop aGVHD respond to currently available treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b408d2f3e3ba3775b7f7f8b44075c7e
https://doi.org/10.1182/blood-2021-153360
https://doi.org/10.1182/blood-2021-153360
Autor:
Sean M. Devlin, Eric G. Pamer, Elizabeth Halton, Guido Ghilardi, Raymone Pajarillo, Emmanuel A Dwomoh, Andrea Facciabene, James N. Gerson, Maria Lia Palomba, Noelle V. Frey, Jonathan U. Peled, Elise A. Chong, Annelie Clurman, David L. Porter, Aishat Afuye, Kimberly Amelsberg, Melody Smith, Martina Pennisi, Marcel R.M. van den Brink, Alfred L. Garfall, Josel D. Ruiz, Emily Fontana, Marco Ruella, Justin R. Cross, Isabelle Riviere, Antonio L.C. Gomes, John B. Slingerland, Anqi Dai, Tania Jain, Ying Taur, Daniel J. Landsburg, Carl H. June, Silvia Beghi, Eric R. Littmann, Renier J. Brentjens, Jonas Schluter, Sunita D. Nasta, Pamela S Herrera, Jakub Svoboda, Paul A Giardina, Michel Sadelain, Craig W. Freyer, Miguel-Angel Perales, Stephen J. Schuster, Gabriel K Armijo, Saar Gill, Jae H. Park, Sergio Giralt, Shannon H. Gier
Publikováno v:
Blood. 138:253-253
Introduction: Cellular immunotherapy with CD19-targeted chimeric antigen receptor (CAR) T cells has provided new therapeutic options for patients with high-risk hematologic malignancies. Following this therapy, patients may experience disease relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c715d18f483259d1e263446d9e8551e
https://doi.org/10.1182/blood-2021-153945
https://doi.org/10.1182/blood-2021-153945
Autor:
Blake D. Hansen, Sylvia A. Huisman, Lynne M. Kerr, Ian D. Krantz, Matthew A. Deardorff, Jason A. Mills, Alena Egense, Jeremy Morgan, Meng Wu, Dale Dorsett, Devanshi Mehta, Olivia L. Katz, Katsuhiko Shirahige, Sarah E. Noon, Chiara Bettale, Pamela S. Herrera, Richard E. Haaland, Joseph P. McCleery, Antonie D. Kline, Cheri S. Carrico, Jo Moss, Siddharth Srivastava, Emily Taylor-Snell, Jennifer L. Gerton, Marco A. Grados, Antonio Musio, Anne L. Calof, Julia A. Horsfield
Publikováno v:
American journal of medical genetics. Part A, 173(5), 1172-1185. Wiley-Liss Inc.
Cornelia de Lange Syndrome (CdLS) is due to mutations in the genes for the structural and regulatory proteins that make up the cohesin complex, and is considered a cohesinopathy disorder or, more recently, a transcriptomopathy. New phenotypes have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::555518f8640e766b035b33ceca64ea45
https://doi.org/10.1002/ajmg.a.38161
https://doi.org/10.1002/ajmg.a.38161
Autor:
Lanfranco Leo, Ian D. Krantz, Alyssa L. Gagne, Zhe Zhang, Jesus A Tintos-Hernandez, Deborah McEldrew, Xilma R. Ortiz-Gonzalez, Jason A. Mills, Pamela S. Herrera, Ramakrishnan Rajagopalan, Maninder Kaur
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Cornelia de Lange syndrome (CdLS) is a complex disorder with multiple structural and developmental defects caused by mutations in structural and regulatory proteins involved in the cohesin complex. NIPBL, a cohesin regulatory protein, has been identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d7be4e6e5af4b0da7a0489ce63a2f65
https://doi.org/10.1038/s41598-018-19173-9
https://doi.org/10.1038/s41598-018-19173-9